These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 18171347

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures.
    Montgomery A, Ferral H, Vasan R, Postoak DW.
    Cardiovasc Intervent Radiol; 2005; 28(3):307-12. PubMed ID: 15886944
    [Abstract] [Full Text] [Related]

  • 3. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE, Darwish WM, Davies MG, Waldman DL.
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Results of a retrospective multicenter trial of the Viatorr expanded polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt creation.
    Charon JP, Alaeddin FH, Pimpalwar SA, Fay DM, Olliff SP, Jackson RW, Edwards RD, Robertson IR, Rose JD, Moss JG.
    J Vasc Interv Radiol; 2004 Nov; 15(11):1219-30. PubMed ID: 15525740
    [Abstract] [Full Text] [Related]

  • 7. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
    Harrod-Kim P, Saad WE, Waldman D.
    J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Oct; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 12. Transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension using memotherm stents: a prospective multicenter study.
    Domagk D, Patch D, Dick R, Grosso M, Rousseau H, Otal P, Goffette P, Heinecke A, Drees M, Domschke W, Menzel J.
    Cardiovasc Intervent Radiol; 2002 Oct; 25(6):506-12. PubMed ID: 12183763
    [Abstract] [Full Text] [Related]

  • 13. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Oct; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 14. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites.
    Ochs A, Rössle M, Haag K, Hauenstein KH, Deibert P, Siegerstetter V, Huonker M, Langer M, Blum HE.
    N Engl J Med; 1995 May 04; 332(18):1192-7. PubMed ID: 7700312
    [Abstract] [Full Text] [Related]

  • 15. [Effects of percutaneous intrahepatic portosystemic shunt on splanchnic and systemic hemodynamics in patients with portal hypertension].
    François E, García-Pagán JC, Bru C, Feu F, Gilabert R, Escorsell A, Bosch J, Rodés J.
    Gastroenterol Hepatol; 1997 Jan 04; 20(1):1-4. PubMed ID: 9072189
    [Abstract] [Full Text] [Related]

  • 16. How much reduction in portal pressure is necessary to prevent variceal rebleeding? A longitudinal study in 225 patients with transjugular intrahepatic portosystemic shunts.
    Rössle M, Siegerstetter V, Olschewski M, Ochs A, Berger E, Haag K.
    Am J Gastroenterol; 2001 Dec 04; 96(12):3379-83. PubMed ID: 11774952
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S, Singh R, Yoselewitz M.
    J Vasc Interv Radiol; 2004 Dec 04; 15(12):1431-4. PubMed ID: 15590801
    [Abstract] [Full Text] [Related]

  • 20. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting.
    Wallace MJ, Madoff DC, Ahrar K, Warneke CL.
    Cancer; 2004 Jul 15; 101(2):337-45. PubMed ID: 15241832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.